Summary

US Smart Pill Technology Market is valued at approximately USD 1.01 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.79% over the forecast period 2024-2032. The US Smart Pill Technology is advancing the development and use of swallowable medical devices for various diagnostic and therapeutic functions within the body. These pills, equipped with sensors, cameras, and electronic parts, track physical states, collect data, and transmit information to external devices. Some smart pills administer medication at specific locations in the digestive system, monitor vital signs, detect diseases, and provide instant responses. This technology aims to enhance patient care by improving diagnostics, and treatment accuracy, and enabling remote health monitoring. Several trends are emerging in the US Smart Pill Technology Market. There is a growing occurrence of long-term illnesses, driving demand for precise diagnostic tools. Integration of Artificial Intelligence (AI) and Internet Of Things (IoT) technologies into smart pills enhances real-time health monitoring and data analysis, leading to improved patient outcomes. Moreover, there is a shift towards less invasive methods, making smart pills an attractive alternative to traditional diagnostics. Rising healthcare costs are increasing the need for cost-effective and efficient medical options in the US Smart Pill Technology Market. Advancements in wireless communication technologies simplify data transmission, boosting the utilization of smart pills. These highlight the opportunities and progress in the US Smart Pill Technology market.

The US Smart Pill Technology Market is experiencing significant growth, primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and gastrointestinal conditions. This has fueled the demand for more effective diagnostic and therapeutic solutions, with smart pills offering a non-invasive and efficient way to monitor and manage these conditions. Advancements in healthcare technologies, including miniaturized sensors, wireless communication, and data analytics, have significantly enhanced the capabilities of smart pills, leading to improved diagnostic accuracy, real-time monitoring, and personalized treatment options. Moreover, the increasing healthcare expenditure in the US has spurred a greater focus on cost-effective healthcare solutions, with smart pills enabling early disease detection, reduced hospitalizations, and improved treatment outcomes. The demand for remote patient monitoring is also on the rise, particularly for elderly patients and those with chronic conditions, further driving the adoption of smart pill technology. A supportive regulatory environment in the US has encouraged innovation in healthcare technologies, prompting companies to invest in research and development, resulting in the introduction of new and advanced smart pill technologies in the market. However, high development and manufacturing costs associated with smart pills can be a barrier to entry for many companies. Data privacy and security concerns also pose challenges for the US Smart Pill Technology Market.


Major market players included in this report are:
Medtronic, Inc.
Capsule Technologies, Inc.
Medisafe America LLC
Siemens Medical Solutions USA, Inc.
Bio-Images Research LLC
Check-Cap Inc.
Pentax Of America, Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Olympus Corporation of the Americas
Boston Scientific Corporation

The detailed segments and sub-segments of the market are explained below:

By Application
Capsule Endoscopy
Drug Delivery
Patient Monitoring

By Target Area
Esophagus
Stomach
Small Intestine
Large Intestine

By Disease Indication
Barrett's Esophagus
Small Bowel Diseases
Colon Cancer
Others

By End User
Hospitals and Clinics
Diagnostic Centres
Research Centres

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Smart Pill Technology Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Smart Pill Technology Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Application
2.2.2. By Target Area
2.2.3. By Disease Indication
2.2.4. By End User
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Smart Pill Technology Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Smart Pill Technology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Smart Pill Technology Market Size & Forecasts by Application 2022-2032
5.1. Capsule Endoscopy
5.2. Drug Delivery
5.3. Patient Monitoring
Chapter 6. US Smart Pill Technology Market Size & Forecasts by Target Area 2022-2032
6.1. Esophagus
6.2. Stomach
6.3. Small Intestine
6.4. Large Intestine
Chapter 7. US Smart Pill Technology Market Size & Forecasts by Disease Indication 2022-2032
7.1. Barrett's Esophagus
7.2. Small Bowel Diseases
7.3. Colon Cancer
7.4. Others
Chapter 8. US Smart Pill Technology Market Size & Forecasts by End User 2022-2032
8.1. Hospitals and Clinics
8.2. Diagnostic Centres
8.3. Research Centres
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Medtronic, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Capsule Technologies, Inc.
9.3.3. Medisafe America LLC
9.3.4. Siemens Medical Solutions USA, Inc.
9.3.5. Bio-Images Research LLC
9.3.6. Check-Cap Inc.
9.3.7. Pentax Of America, Inc.
9.3.8. Takeda Pharmaceuticals U.S.A., Inc.
9.3.9. Olympus Corporation of the Americas
9.3.10. Boston Scientific Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes